2nd Mastering HR Summit 2011

26 - 27 October 2011, Amsterdam, Netherlands.
North West Business GroupNorth West Business Group invites to attend the 2nd Mastering HR 2011 Conference, geared towards Vice Presidents, Directors, and Managers involved in Talent, recruitment and compensation and benefits. Based on the success of the previous Mastering HR conference in March 2011, the hot topics for a one-stop shop approach to international HR issues have been combined.

Driven by increasing recognition of the importance of human capital in today's competitive market, the organization's expectation of HR is continuously getting higher. The role of HR is evolving from an operational department to a strategic one. HR professionals need to advance their skills and equip the team with new and ever-changing ideas. Attending this exclusive conference will bring together top experts from across Europe for a very intensive and interactive meeting. Benefit from the hands-on approach and unique case studies from top players in the industry. This forum sets a platform for practitioners from around the world to discuss and share strategies for their future success.

The event will focus on the most current topics in the HR industry such as:

  • A Cohesive Approach to Recruiting, Hiring and Accelerating Talent
  • Utilizing Social Media to Reach Specific Skill Set Employees
  • Evaluating Current Trends In Recruitment And Retention
  • How Connecting Performance Management And Talent is going to help you?
  • Using Talent Development Programs As A Vehicle For The Corporate Strategy
  • Recruiting the Best Talent By Selling More Than Just A Salary - The Role Of Culture
  • Effective Remuneration Planning To Succeed In a Tight Labour Market
  • Effectively Communicating Remuneration And Benefits To Employees
  • How Recognition and Reward Can Motivate Employees to Build and Deliver Authentic Brand Experiences

Joins some of the experts like:

  • Genzyme, Vice President HR - European Commercial, CDMA
  • TeliaSonera, Vice President & HR Business Partner
  • Santander, Head of Talent Development & Performance
  • SAP, Director Learning & Talent Management
  • KPN, HR Director
  • IBM HR, Director Benelux
  • Astellas Pharma, Director Human Resources
  • Accenture, Country Director HR
  • Pfizer, Talent Acquisition COE Lead
  • Heinz, Director Compensation & Benefits
  • Zurich Financial Services, UK Head of Resourcing
  • IBM, Workforce Partner Benelux
  • UBS, HR Executive Director
  • Magnate Global Group MGG, Group CHRO
  • European Personnel Selection Office, Director of EPSO
  • IBM HR, Director Benelux
  • And many more ...

Who should attend?
This conference is designed to attract key decision makers from the HR industry with key job titles including: Managing Directors, Country Managers, General Managers, Vice Presidents, Regional Directors/Heads, Directors, Department Heads, Managers, etc.

Benefits of attending include:

  • Hearing from experts actively working in the industry
  • Participating in the panel discussions
  • Quizzing industry experts on the ideas that worked
  • Exchanging ideas with senior professionals across Europe

For further information and registration, please visit:
http://www.nwbg.eu/all-events/2nd-master-hr-sumit-2011/

Most Popular Now

New strategy to treat Parkinson's disease

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harmful ge...

AI could offer warnings about serious side effects…

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ dama...

OPKO and Pfizer announce positive Phase 3 top-line…

OPKO Health Inc. (NASDAQ: OPK) and Pfizer Inc. (NYSE: PFE) announced that the global Phase 3 trial evaluating somatrogon dosed once-weekly in pre-pubertal children with g...

Trastuzumab deruxtecan granted FDA Priority Review…

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has accepted for review the Biologics Lice...

The Bristol-Myers Squibb-Pfizer Alliance and Fitbi…

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of a...

Nplate® (romiplostim) now approved for earlier use…

Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for Nplate® (romiplostim...

Bayer launches LifeHub UK focused on artificial in…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The...

Novartis announces that Jakavi® (ruxolitinib) meet…

Novartis today announced positive topline results from the Phase III REACH2 study evaluating Jakavi® (ruxolitinib) in patients with steroid-refractory acute graft-versus-...

Amgen recommends rejection of 'mini-tender' offer …

Amgen (NASDAQ:AMGN) today announced that it has been notified of an unsolicited "mini-tender" offer dated Oct. 11, 2019, made by TRC Capital Corporation, a private Canadi...

Antibody-based eye drops show promise for treating…

Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodi...

First entirely digital clinical trial encourages p…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new s...

Abbott and Omada Health partner to offer integrate…

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) ...